Vistagen Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VTGN and other ETFs, options, and stocks.About VTGN
Vistagen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company, which engages in developing and commercializing medication and treatment for anxiety, depression, and other central nervous system disorders. Its product portfolio includes Fasedienol (PH94B) nasal spray for social anxiety disorder, Itruvone (PH10) nasal spray for depression disorders, AV-101 oral NMDR glycine site antagonist for depression and neurological disorders, PH15 acute treatment for improvement of cognition, PH80 acute management of vasomotor symptoms due to menopause, and PH284 acute management of Wasting syndrome (Cachexia).
VTGN Key Statistics
Stock Snapshot
As of today, Vistagen Therapeutics(VTGN) shares are valued at $0.17. The company's market cap stands at 7.52M, with a P/E ratio of -0.11.
On 2026-11-05, Vistagen Therapeutics(VTGN) stock moved within a range of $0.17 to $0.18. With shares now at $0.17, the stock is trading 0.0% above its intraday low and -10.4% below the session's peak.
Trading volume for Vistagen Therapeutics(VTGN) stock has reached 1.03M, versus its average volume of 811.9K.
Over the past 52 weeks, Vistagen Therapeutics(VTGN) stock has traded between a high of $5.14 and a low of $0.17.
Over the past 52 weeks, Vistagen Therapeutics(VTGN) stock has traded between a high of $5.14 and a low of $0.17.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.